LAB: Standard BioTools Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Stocks in this Quantisnow insightIndustrials
Historical context for LAB
Across the 7 sessions after earlier LAB headlines, the stock closed higher 4 times and lower 3 times, with a median move of 3.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | LAB | SPY |
|---|---|---|---|
| Apr 21, 2026 | Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 | -1.0% | -0.7% |
| Feb 25, 2026 | Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results | +1.7% | +0.8% |
| Feb 10, 2026 | Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 | -1.6% | -0.3% |
| Jan 8, 2026 | Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue | +20.3% | -0.0% |
| Nov 19, 2025 | Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry | +3.2% | +0.4% |
| Nov 5, 2025 | Standard BioTools Reports Third Quarter 2025 Financial Results | -4.2% | +0.3% |
Quantisnow market dataNASDAQ
LAB
Standard BioTools Inc.
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Listed since
- 2011
Get push alerts for LAB
Full LAB profile on Quantisnow Follow LAB and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time